Navigation Links
Organovo Reports Q2 2012 Financial Results, Provides Business Update
Date:8/15/2012

SAN DIEGO, Aug. 15, 2012 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQB: ONVO) ("Organovo") a three-dimensional biology company focused on delivering breakthrough 3-D bioprinting technology, today reported unaudited financial results for the period ended June 30, 2012.

(Logo:  http://photos.prnewswire.com/prnh/20120813/MM55537LOGO)

Organovo is focused on breakthrough 3D bioprinting technology to create tissue on demand for research and medical applications. The company's NovoGen MMX  Bioprinter() is part of a 3D human tissue generation platform that works across a broad array of tissue and cell types to recapitulate in vivo biology. Organovo's bioprinting technology has immediate applications in disease research, drug discovery and development, and toxicology testing. In the future, the Company believes that applications of this technology hold the promise to generate tissues for therapeutic uses.

Second quarter 2012 revenues increased approximately 49% above the same period in 2011. Collaborative research revenues for the second quarter increased approximately 81% over the same period of prior year revenues, but were partially offset by a reduction in grant revenues.  Loss from Operations for the second quarter was approximately $1,449,700. 

Recent Corporate Highlights
On July 17, 2012, Organovo announced the commencement of operations at its new, larger facility in San Diego, California.  The new facility has over three times the capacity of Organovo's previous headquarters and is expected to facilitate the Company's needs to grow staff and research and development output.

On July 9, 2012, Organovo announced the receipt of two issued patents.  The patents consisted of the issuance in the United States of a patent to which the Company owns the exclusive license from the University of Mis
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
3. Organovo Holdings Appoints James T. Glover to Board of Directors
4. ULURU Inc. Reports Second Quarter 2012 Financial Results
5. China Pharma Holdings, Inc. Reports Second Quarter 2012 Financial Results
6. Sinovac Reports Unaudited Second Quarter 2012 Financial Results
7. Nephros Reports Second Quarter 2012 Financial Results
8. Tengion Reports Second Quarter 2012 Financial Results
9. Synthetic Biologics Reports Second Quarter 2012 Financial Results
10. Vermillion Reports Second Quarter 2012 Results
11. Pressure BioSciences, Inc. Reports 70% Revenue Growth for Second Consecutive Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015  The strongest driver of demand in ... elderly population, according to Kalorama Information. The finding ... healthcare market research publisher, Global Orthopedic Device ... factors such as obesity is contributing to the ... product designs and the trend toward cost effective ...
(Date:3/4/2015)... Alimera Sciences, Inc. (NASDAQ: ALIM ) ... research, development and commercialization of prescription ophthalmic pharmaceuticals, ... and year ended December 31, 2014. ... Alimera Sciences, most notably having received U.S. FDA ... of diabetic macular edema," said Dan Myers, president ...
(Date:3/4/2015)... -- Acsis Inc., the market leader for supply chain ... be hosting a free webinar on supply chain visibility ... Manufacturing Efficiency and Optimize Supply Chain Visibility," will take ... Presenters John DiPalo , Chief ... Chief Information Officer for Roosevelt Paper, will be addressing ...
Breaking Medicine Technology:Kalorama: Growing Elderly Population Drives Orthopedic Device Market 2Kalorama: Growing Elderly Population Drives Orthopedic Device Market 3Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 2Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 3Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 4Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 5Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 6Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 7Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 8Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 9Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 10Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 11Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 12Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 13Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 14
(Date:3/4/2015)... 2015 TROY Healthcare Solutions will be ... the ultimate level of security for prescriptions, in Houston, ... Plaza Medical Center located at 6633 Travis Street from ... 7 AM, TROY Healthcare Solutions will host a continental ... offer brief presentations each hour to introduce attendees to ...
(Date:3/4/2015)... NY (PRWEB) March 04, 2015 Smokers ... breakthrough marketing campaign called 'We Love Smokers' from Aqua-Tine, ... for tobacco. , "It’s important to establish a ... true to it. Our idea, 'We Love Smokers' elevates ... point of view. We created a bold tone of ...
(Date:3/4/2015)... Starting February 2015, Dr. Joseph King of King ... new location in Surrey. , In addition to providing ... Chu also provide comprehensive ophthalmology services, including cataract surgery. ... Cataract and Laser (FVCL). This state of the art ... and Surgeons of British Columbia. Fraser Valley Cataract and ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 " Optrix ... part of its monthly Tech Report, which takes a ... services available to consumers. Scott Steinberg, a special reporter ... review and shared with viewers how they have an ... The mobile industry is a major player at the ...
(Date:3/4/2015)... 2015 The New Mel Brooks Musical ... will be performed by the award-winning Drama Department of ... March 6-22, 2015, on Fridays, Saturdays and Sundays. Performances ... School (27118 Silver Spur Road, Rolling Hills Estates, ... program or may be purchased on-line at https://sites.google.com/site/penhidrama ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 2Health News:TROY Healthcare to Offer Prescription Solutions that can save a Hospital $100,000 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:King LASIK relocates to Surrey, British Columbia 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2
... received the US Food and Drug Administration (FDA)'s final ... treatment of major depressive disorders in adults. ... Laboratories Limited (RLL), announced Friday that FDA approval permitted ... five doses from 25 mg to 200 mg. ...
... between zinc supplementation and reduced atherosclerosis in rabbit models ... their hypothesis that the effect may be due to ... ,Researchers from the National University of Singapore reported in ... that supplementation of a high cholesterol diet with zinc ...
... biggest controversies in fetal surgery and the cause of ... the world: What's the best way to treat twin-twin ... requiring fetal surgery and the leading cause of mortality ... TTTS, conducted at 17 centers in the United States, ...
... Trevis Smith, once- upon- a -time hero of Regina//. ... assault last Thursday. , The 31-year-old football player was ... has been going on for some time. ,The ... minimum two years and maximum, life. ,Two women who ...
... last year, dropping significantly from the previous year's number of ... ,The number of homes found to be breeding ... year, compared to 53 in 2005, the report said. ... launched by the government, it said. ,The ...
... years, researchers at Oncolytics Biotech have been developing a harmless ... been accumulating data that suggests in addition to directly killing ... mount a separate, powerful and long lasting defence against cancer. ... for the past year. On January 10, 2007, Dr. Sheila ...
Cached Medicine News:Health News:More Support for Zinc-antiatherogenic Link 2Health News:More Support for Zinc-antiatherogenic Link 3Health News:Timeliness, a Critical Factor in Treating TTTS 2Health News:Timeliness, a Critical Factor in Treating TTTS 3Health News:Scientists Develop a Harmless Multi-Tasking Reovirus 2
... Pyrogallol Red Molybdate dye binding method ... for total protein quantitation with greater ... or cerebrospinal fluid (CSF) in manual ... four reagent standards (level 2, 3, ...
SPOT RT KE and RT SE digital camera lines provide maximum performance in a mid-line scientific camera system....
The AutoSet Respond offers ResMeds unique AutoSet algorithm and product quality in a convenient, affordable model. The AutoSet algorithm responds to the patients pressure needs on a breath-by-breath ...
... CPAP System includes the 420E Auto-CPAP model, ... enjoy the advantages of the worlds smallest ... The GoodKnight 420E model records up to ... other features of the 420S model. The ...
Medicine Products: